Search  in | Advanced
   Print  
Public Meetings

 
IN THIS SECTION


QUICK LINKS
Statement on National Drug Code

FDA Proposed Rule on National Drug Code (PDF) 
  

Federal government agencies periodically call public meetings where interested parties can share their views on issues that have a potential impact on the field of transfusion medicine and cellular or biological therapies.

This section includes information on current and past meetings, including meeting summaries, resources and analysis as well as quick links to other relevant materials.


NRC Public Meeting on Cesium Chloride Uses, Including Blood Irradiators - 9/29-9/30/08
FDA Public Meeting on National Drug Code - 12/11/06
FDA Public Workshop on the Licensure of Apheresis Blood Products - 8/15/07

Last modified on 10/17/2008 11:21:59 AM
What's New!
AABB Weekly Report - December 19, 2008
Details
AABB Patient and Donor Safety Center Named a Patient Safety Organization by Department of Health and Human Services
Details
The Proposed 4th edition of Standards for Perioperative Autologous Blood Collection and Administration
Details
The Proposed 26th edition of Standards for Blood Banks and Transfusion Services
Details
CMS Publishes 2009 Hospital Outpatient Prospective Payment System Rule
Details
FDA Liaison Meeting Summary
Details
2007 National Blood Collection and Utilization Survey
Details
Call for AABB Award Nominations
Details
Association Bulletin #08-04 - Strategies to Reduce Adverse Reactions and Injuries in Younger Donors
Details
First Ever National Biovigilance Network in the U.S. Reaches $1 Million in Funding, Prepares for Fall Pilot Launch
Details
List of AABB-Accredited Facilities with Approved Variances for ISBT 128
Details